Ligand Pharmaceuticals
LGND
#4162
Rank
NZ$3.84 B
Marketcap
$203.41
Share price
-1.70%
Change (1 day)
69.58%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.53

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.77. In 2022 the company made an earnings per share (EPS) of -$3.49 a decrease over its 2021 EPS that were of $6.10.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.53-172.6%
2022-$3.49-157.23%
2021$6.10-2571.43%
2020-$0.25-100.46%
2019$53.97353.48%
2018$11.901025%
2017$1.06-700%
2016-$0.18-100.87%
2015$20.381859.32%
2014$1.045.36%
2013$0.998.0704505322479E+18%
2012$0.0000000000-100%
2011$0.86-194.23%
2010-$0.92548.38%
2009-$0.14-98.7%
2008-$10.90-136.52%
2007$29.83-787.8%
2006-$4.34-14.58%
2005-$5.08-21.31%
2004-$6.45-55.15%
2003-$14.3981.33%
2002-$7.932.74%
2001-$7.72-45.93%
2000-$14.28-14.56%
1999-$16.72-45.52%
1998-$30.68-3.97%
1997-$31.95132.31%
1996-$13.75

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$24.95 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.63-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.17 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.21 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.28 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.57 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.00 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.03 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.84 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA